The Clinical and Translational Pilot Award Program is funded through the NIH National Center for Advancing Translational Sciences (UL1TR0002548), which defines translation as “the process of turning observations in the laboratory, clinic and community into interventions that improve the health of individuals and the public — from diagnostics and therapeutics to medical procedures and behavioral changes.”
Applications are open now for funding through this program.
Projects are intended to:
- Explore possible innovative new leads or new directions for established investigators;
- Stimulate investigators from other areas to lend their expertise in research in CTS; and
- Provide initial support to establish proof of concept.
Projects must be feasible within the proposed timeframe, have high methodological and scientific quality, and answer important scientific questions. The ability of applicants to clearly enunciate the gap and value for moving “observations/associations” toward “patient-centric outcomes” will be an essential review criterion.
A minimum of two, but up to six, grants will be awarded with budgets limited to $50,000 in direct costs. Research proposed in the application must be accomplished by June 30, 2024 (project start is July 1, 2023). Carry-over of funds is not permitted.
Annual pilot timeline
- Letter of Intent (LOI) due: Oct. 31 at 11:59 p.m. via InfoReady
- LOI decisions and communication to applicants by Dec. 15 (via email)
- Invited proposals/full applications due Feb. 15 at 11:59 p.m. via InfoReady
- Scientific Review Committee to meet the fourth week of February 2023
- Grant awardees to be notified the third week of March 2023
- Primary Investigator, grant team and CTSC will meet to discuss terms and conditions of award during June 2023
- Funding period: July 1, 2023 to June 30, 2024
2023 Annual Pilot Awards are contingent upon the CTSC’s NIH grant renewal. The CTSC will be notified of its renewal funding towards the end of May 2023. If funded, annual pilot grants would be able to begin on or around July 1, 2023.
For more information, see the Clinical and Translational Science Collaborative website.